f*******b
发帖数: 186 | 1 Ivy school PhD, 2-Year Post-doc, Research Scientist in a Fortune 500 company.
Publication: 23 journal + 1 patent + 6 conference abstract
Citation: 150;
Reviewers: 8 journals + 4 conferences
Media report: some major Chinese media report, but without my name.
Is this possible for Eb1a? |
b********9
发帖数: 1061 | |
h*********r
发帖数: 290 | 3 Doable case. Why not Eb1b?
company.
【在 f*******b 的大作中提到】
: Ivy school PhD, 2-Year Post-doc, Research Scientist in a Fortune 500 company.
: Publication: 23 journal + 1 patent + 6 conference abstract
: Citation: 150;
: Reviewers: 8 journals + 4 conferences
: Media report: some major Chinese media report, but without my name.
: Is this possible for Eb1a?
|
b*********0
发帖数: 1030 | 4 doable
company.
【在 f*******b 的大作中提到】
: Ivy school PhD, 2-Year Post-doc, Research Scientist in a Fortune 500 company.
: Publication: 23 journal + 1 patent + 6 conference abstract
: Citation: 150;
: Reviewers: 8 journals + 4 conferences
: Media report: some major Chinese media report, but without my name.
: Is this possible for Eb1a?
|
l******5
发帖数: 3030 | 5 再搞10个REVIEW吧
company.
【在 f*******b 的大作中提到】
: Ivy school PhD, 2-Year Post-doc, Research Scientist in a Fortune 500 company.
: Publication: 23 journal + 1 patent + 6 conference abstract
: Citation: 150;
: Reviewers: 8 journals + 4 conferences
: Media report: some major Chinese media report, but without my name.
: Is this possible for Eb1a?
|
l*******y
发帖数: 30 | 6 Your case is very strong.
My background (less than 5 papers, less than 10 citations, less than 10
reviews) is much worse than yours and got EB1A approved recently.
Go for it!
【在 l******5 的大作中提到】
: 再搞10个REVIEW吧
:
: company.
|
b*********r
发帖数: 7139 | 7 your case is too special:)
【在 l*******y 的大作中提到】
: Your case is very strong.
: My background (less than 5 papers, less than 10 citations, less than 10
: reviews) is much worse than yours and got EB1A approved recently.
: Go for it!
|
